ORAL RIBAVIRIN THERAPY FOR LIFE- THREATENING RESPIRATORY SYNCYTIAL VIRUS INFECTION IN AN INFANT: A CASE REPORT
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: HSIEH, Yi Chieh (Far Eastern Memorial Hospital, Pharmacy, New Taipei City, China Taiwan)
- Co-author(s): Yi Chieh Hsieh
For infants with severe acute respiratory syncytial virus (RSV) infection, nebulised ribavirin is the treatment of choice. However, the nebulized formulation is not available in Taiwan. The use of oral ribavirin for the treatment of RSV infections is not yet approved by FDA.
Reviewing a life- threatening RSV infection in an infant.
This case.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.